In Other News

• Blood Test Guides More Effective Ovarian Cancer Treatment

• Unique Immune Signatures Distinguish Rare Autoimmune Condition from Multiple Sclerosis

• Chemical Imaging Probe Could Track and Treat Prostate Cancer

• Unique Immune Signatures Distinguish Rare Autoimmune Condition from Multiple Sclerosis

• Chemical Imaging Probe Could Track and Treat Prostate Cancer

• Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

• Liquid Biopsy Test to Enable Earlier Diagnosis of Numerous Cancer Types

• Blood Protein Profile Indicates Early-Onset Coronary Heart Disease

• Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

• Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

• Abbott Acquires Cancer-Screening Company Exact Sciences

• New DNA Test Tracks Spread of Parasitic Disease from Single Sample

• Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems

• Hidden Blood Biomarkers to Revolutionize Diagnosis of Diabetic Kidney Disease

• Genetic Testing Trifecta Predicts Risk of Sudden Cardiac Death and Arrhythmia

• MEDICA 2025 and COMPAMED 2025 Conclude as Global Healthcare Leaders Unite on Innovation and Future Strategy

• Genetic Testing Trifecta Predicts Risk of Sudden Cardiac Death and Arrhythmia

• Randox Presents Full Suite of Reagent, Analyzer, and Quality Control Innovations

• Ozelle Unveils Next-Generation AI-Driven Complete Blood Morphology Solution

• Maternal Blood Test Detects Pre-Eclampsia Risk Before Symptoms Develop

• Vircell Highlights Diagnostic Innovations in Infectious Diseases at MEDICA 2025

• DiaSys Presents Comprehensive Clinical Chemistry and Immunoturbidimetry Solutions

• Roche and Freenome Collaborate to Develop Cancer Screening Tests